Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
I’ll be keen to stay in touch if we can find a way
Will shareholders be offered a price per share at the point the company is delisted? Or is it a case of 1) taking the decision to sell between now and the delist date in January or 2) holding in the private company at 750/1 dilution and hoping for a future listing? Also hoping that the shares aren’t diluted even further!?
Take a look at their Instagram page sindhcmhouse. Third post in there’s a transcript of their session today. Click to translate and they outline plans for infrastructure/access roads, water supply and detailing how they intend to house the homeless. The translation isn’t perfect but it states a visit by China president, block 6 and 1 decision to complete in 2 months, references to start “all projects for the c pack” (??) and gas and coal projects for diesel making projects.
I’m in
https://www.investopedia.com/ask/answers/nasdaq-listing-requirements/
https://clinicaltrials.gov/ProvidedDocs/92/NCT03813992/Prot_000.pdf
I might be missing something here but if you look at all the tie ups with a long list of artists (and the labels they are associated with) then doesn't that give a good impression as to where this is heading?
Can anyone summarise what the key investor document and costs/charges are when you purchase FFWD shares via HSBC? If I'm understanding correctly, they view this as a high risk fund with a management charge at 12.11%
Here’s a balanced view - take a read of Amara’s law and understand the technology hype cycle. A few standouts: 1. VR headset sales forecast to grow 7-10 fold by 2023 from 4-6m annually to 28-60m. 2. Melody have built a significant presence, bringing many leading experts together - if this is just hype, then these people would have no real interest in their career development and credibility. 3. The product works and with such an innovative approach, the company will grow into other areas and markets. 4. Granted a lot of news has yet to materialise. 5. 19p to sub 3p is a ride down but the risk-reward is still off the scale Of course I’m in and of course I’m averaging down. I’d rather be invested in something that could be life-changing over the next 5 years than grow the same money by a few percent over the same period. There will be some peaks and troughs to come no doubt and I plan to spread risk accordingly through those. And if it doesn’t materialise then I got it wrong. All the doom and gloomers can have a go at my ‘ramping’ but this is the stock market and so nobody knows. I’m sure they will agree that on the next wave up, wee attract not only the new investors but those who have been in/out/sat on the fence and fear missing out. I’m sure there will be plenty of those 3 figure % increase days to come, I just hope it’s from 3p and not 1p
Nothing is a given but look at it like this. In 2011, the FDA approved Benalytsta the current standard of care treatment, despite their being more deaths and serious infections compared with placebo. Granted there were far more patients but this drug works and, thus, I'm sure its got a positive future.
Signal to drop?